Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.
NY-ESO-1, a member of the cancer-testis family of antigens, is expressed in a subset of a broad range of different human tumor types. Patients with advanced NY-ESO-1-expressing tumors frequently develop humoral immunity to NY-ESO-1, and three HLA A2-restricted peptides were defined previously as tar...
Main Authors: | Jäger, E, Nagata, Y, Gnjatic, S, Wada, H, Stockert, E, Karbach, J, Dunbar, P, Lee, S, Jungbluth, A, Jäger, D, Arand, M, Ritter, G, Cerundolo, V, Dupont, B, Chen, Y, Old, L, Knuth, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
Similar Items
-
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.
by: Gnjatic, S, et al.
Published: (2000) -
LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancers
by: Knuth A, et al.
Published: (2004-07-01) -
Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.
by: Chen, J, et al.
Published: (2000) -
NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.
by: Chen, J, et al.
Published: (2015) -
NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses.
by: Wadle, A, et al.
Published: (2010)